The 1-3 mg/mL range described in most community protocols sits in the comfortable middle
In fact, clinicians have reported numerous advantages using these new, advanced techniques: Changes in mucosal and vascular patterns can be identified which can predict histology indicative of dysplasia, resulting in a potentially improved ability to screen for Barretts Esophagus, detect dysplasia in established Barretts esophagus and detect recurrent dysplasia/neoplasia after ablation
Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS
At Wellorithm, we believe that every patient deserves to feel confident and safe when managing their metabolic health
Read more about us Updated September 9, 2023 Added by Hubayobi